๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

โœ Scribed by Aronne, L J; Tonstad, S; Moreno, M; Gantz, I; Erondu, N; Suryawanshi, S; Molony, C; Sieberts, S; Nayee, J; Meehan, A G


Book ID
109866750
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
711 KB
Volume
34
Category
Article
ISSN
1476-5497

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES